BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 9145215)

  • 1. Effects of betamipron on cisplatin nephrotoxicity and its pharmacokinetics in rats.
    Tokunaga J; Kobayashi M; Kitagawa A; Nakamura C; Arimori K; Nakano M
    Biol Pharm Bull; 1997 Apr; 20(4):386-91. PubMed ID: 9145215
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protective effects of N-benzoyl amino acids on cisplatin nephrotoxicity in rats.
    Tokunaga J; Kobayashi M; Kitagawa A; Nakamura C; Arimori K; Nakano M
    Biol Pharm Bull; 1996 Nov; 19(11):1451-6. PubMed ID: 8951163
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Betamipron reduces cisplatin nephrotoxicity in rodents without modifying its antileukemic activity in mice.
    Tokunaga J; Kobayashi M; Nakamura C; Kitagawa A; Arimori K; Nakano M
    Ren Fail; 1997 May; 19(3):425-38. PubMed ID: 9154659
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protective effects of betamipron on renal toxicity during repeated cisplatin administration in rats and protective mechanism.
    Tokunaga J; Kobayashi M; Kitagawa A; Nakamura C; Arimori K; Nakano M
    Ren Fail; 1998 Jan; 20(1):27-38. PubMed ID: 9509558
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protective effect of N-benzoyl-beta-alanine against cisplatin nephrotoxicity in rats.
    Tokunaga J; Kobayashi M; Nakamura C; Kitagawa A; Arimori K; Nakano M
    Ren Fail; 1996 Mar; 18(2):225-40. PubMed ID: 8723360
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of a cisplatin-chondroitin sulfate A complex in reducing the nephrotoxicity of cisplatin.
    Zhang JS; Imai T; Otagiri M
    Arch Toxicol; 2000 Aug; 74(6):300-7. PubMed ID: 11005675
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tiopronin protects against the nephrotoxicity of cisplatin in the rat.
    Zhang JG; Viale M; Esposito M; Lindup WE
    Hum Exp Toxicol; 1999 Dec; 18(12):713-7. PubMed ID: 10627657
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sex differences in protective effect of recombinant human erythropoietin against cisplatin-induced nephrotoxicity in rats.
    Eshraghi-Jazi F; Nematbakhsh M; Pezeshki Z; Nasri H; Talebi A; Safari T; Mansouri A; Mazaheri S; Ashrafi F
    Iran J Kidney Dis; 2013 Sep; 7(5):383-9. PubMed ID: 24072151
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevention of cisplatin nephrotoxicity by exogenous atrial natriuretic peptide.
    Deegan PM; Basinger MA; Jones MM; Hande KR
    Toxicology; 1996 Jan; 106(1-3):159-66. PubMed ID: 8571387
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of rebamipide on cisplatin-induced nephrotoxicity in rats.
    Saad SY; Najjar TA; Al-Sohaibani MO
    Pharmacol Res; 2000 Jul; 42(1):81-6. PubMed ID: 10860639
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cilastatin protects against cisplatin-induced nephrotoxicity without compromising its anticancer efficiency in rats.
    Humanes B; Lazaro A; Camano S; Moreno-Gordaliza E; Lazaro JA; Blanco-Codesido M; Lara JM; Ortiz A; Gomez-Gomez MM; Martín-Vasallo P; Tejedor A
    Kidney Int; 2012 Sep; 82(6):652-63. PubMed ID: 22718191
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protective effects of L-arginine against cisplatin-induced renal oxidative stress and toxicity: role of nitric oxide.
    Saleh S; El-Demerdash E
    Basic Clin Pharmacol Toxicol; 2005 Aug; 97(2):91-7. PubMed ID: 15998355
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thiol and thioether suppression of cis-platinum-induced nephrotoxicity in rats bearing the Walker 256 carcinosarcoma.
    Jones MM; Basinger MA
    Anticancer Res; 1989; 9(6):1937-41. PubMed ID: 2627140
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protection effects of Taurine supplementation against cisplatin-induced nephrotoxicity in rats.
    Saad SY; Al-Rikabi AC
    Chemotherapy; 2002 Mar; 48(1):42-8. PubMed ID: 11901256
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Disparity in actions of rosiglitazone against cisplatin-induced nephrotoxicity in female Sprague-Dawley rats.
    Kumar P; Prashanth KS; Gaikwad AB; Vij M; Barua CC; Bezbaruah B
    Environ Toxicol Pharmacol; 2013 Nov; 36(3):883-90. PubMed ID: 24001946
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nephrotoxicity of acyclovir and cis-diamminedichloroplatinum(II)--effect of co-administration in rats.
    Hannemann J; Wunderle W; Baumann K
    J Cancer Res Clin Oncol; 1992; 118(3):181-6. PubMed ID: 1548282
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative in vivo evaluations of curcumin and its analog difluorinated curcumin against cisplatin-induced nephrotoxicity.
    Sahin K; Orhan C; Tuzcu M; Muqbil I; Sahin N; Gencoglu H; Guler O; Padhye SB; Sarkar FH; Mohammad RM
    Biol Trace Elem Res; 2014 Feb; 157(2):156-63. PubMed ID: 24415068
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rehabilitating role of glutathione ester on cisplatin induced nephrotoxicity.
    Babu E; Ebrahim AS; Chandramohan N; Sakthisekaran D
    Ren Fail; 1999 Mar; 21(2):209-17. PubMed ID: 10088181
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protection against cis-diamminedichloroplatinum-induced nephrotoxicity in rats by N-benzyl-D-glucamine dithiocarbamate.
    Kiyozumi M; Inoue T; Kojima S; Hidaka S; Tsuruoka M
    Toxicology; 1991 Mar; 67(1):41-51. PubMed ID: 2017764
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of the renin-angiotensin system in cisplatin nephrotoxicity.
    Deegan PM; Nolan C; Ryan MP; Basinger MA; Jones MM; Hande KR
    Ren Fail; 1995 Nov; 17(6):665-74. PubMed ID: 8771239
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.